₹ 881.60
-1.85 (-0.21%)Open
893.95High
914Low
866.35Prev Close
883.45P/E
-Median P/E
31.46P/B
3.62Median P/B
4.53Market Cap
81.03BPEG
-Div.Yield
0.17Bid
-Ask
-Large Cap
81.03B Mkt. Cap.Volatility
-Beta
1.15Genie Says
Influencer Count
-Days | BSE | NSE |
---|
5 | 887.22 | 887.57 |
10 | 863.35 | 864.03 |
20 | 845.97 | 846.48 |
50 | 814.85 | 815.35 |
100 | 730.14 | 730.43 |
300 | 601.93 | 602.13 |
BSE
532531NSE
STARISIN
INE939A01011Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche and pharmaceutical products. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.
Arun Pillai
Executive Chairperson of the Board, Managing DirectorBadree Komandur
Group Chief Financial Officer, Executive Director - FinanceRamaraju Pvs
Chief Operating OfficerManjula Ramamurthy
Compliance Officer, Company SecretaryUmesh Kale
Chief Quality Officer